Erythromycin and Benzoyl Peroxide NDC 68682-900

NDC codes

FDA NDC Directory

Product NDC (as listed)68682-900Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68682-0900Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68682-900-23	68682090023	1 KIT in 1 CARTON (68682-900-23) * .8 g in 1 VIAL, PLASTIC (68682-924-08) * 20 g in 1 JAR (68682-923-23)Marketed from Oct 26, 1984

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Erythromycin and Benzoyl Peroxide
Generic name (nonproprietary): erythromycin and benzoyl peroxide
Dosage form: Kit
Labeler: Oceanside Pharmaceuticals
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 050557
Marketing start: Oct 26, 1984
Listing expires: Dec 31, 2026
Identifiers: Product ID 68682-900_eba108cb-67ec-4f94-8fad-0afb3a52899bSPL ID eba108cb-67ec-4f94-8fad-0afb3a52899bSPL set ID be5bce27-bbb7-4503-b609-d89a77ee1e05RxCUI 244374, 308694

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N468682090023 followed by a unit qualifier and the quantity

Package 68682-0900-23. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 3, 2019.

Indications (excerpt from the label)

INDICATIONS AND USAGE Erythromycin-Benzoyl Peroxide Topical Gel is indicated for the topical treatment of acne vulgaris.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 050557

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 050557
Product	Strength	Form · route	Labeler	Product NDC
Benzamycinerythromycin and benzoyl peroxide	—	Kit	Bausch Health US, LLC	0187-5205
Erythromycin and Benzoyl Peroxide	—	Kit	Oceanside Pharmaceuticals	68682-901